Evidence map›Paper›PMID 35899491›Full record

ArticleEMBO reports2022

GSDMD drives canonical inflammasome-induced neutrophil pyroptosis and is dispensable for NETosis.

Dhruv Chauhan, Dieter Demon, Lieselotte Vande Walle, Oonagh Paerewijck, Annalisa Zecchin, Leslie Bosseler, Karin Santoni, Rémi Planès, Silvia Ribo, Amelie Fossoul and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in EMBO reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
6.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 79 citations in OpenAlex.

  1. Review
  2. The gasdermin family: from pyroptosis mechanisms to therapeutic targets.Signal transduction and targeted therapy · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Mechanism of GSDMD in the Pathogenesis ofTransboundary and emerging diseases · 2026
    Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Biomedicines · 2025
    Review
  15. Article
  16. The Immunogenic Role of Self-DNA in T Cell Immunity.Clinical reviews in allergy & immunology · 2025
    Review
  17. Article
  18. Review
  19. Review
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 2 countries.

Dhruv Chauhan *Janssen Immunosciences, World Without Disease Accelerator, Pharmaceutical Companies of Johnson & Johnson, Beerse, Belgium.
Dieter Demon *Department of Internal Medicine and Paediatrics, Ghent University, Ghent, Belgium.
Lieselotte Vande WalleDepartment of Internal Medicine and Paediatrics, Ghent University, Ghent, Belgium.
Oonagh PaerewijckDepartment of Internal Medicine and Paediatrics, Ghent University, Ghent, Belgium.
Annalisa ZecchinJanssen Immunosciences, World Without Disease Accelerator, Pharmaceutical Companies of Johnson & Johnson, Beerse, Belgium.
Leslie BosselerNonclinical Safety, Janssen Research & Development, Pharmaceutical Companies of Johnson & Johnson, Beerse, Belgium.
Karin SantoniInstitute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France.
Rémi PlanèsInstitute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France.ORCID 0000-0003-3695-3965
Silvia RiboDepartment of Internal Medicine and Paediatrics, Ghent University, Ghent, Belgium.ORCID 0000-0001-8983-827X
Amelie FossoulDepartment of Internal Medicine and Paediatrics, Ghent University, Ghent, Belgium.
Amanda GonçalvesVIB-UGent Center for Inflammation Research, VIB, Ghent, Belgium.
Hanne Van GorpDepartment of Internal Medicine and Paediatrics, Ghent University, Ghent, Belgium.
Nina Van OpdenboschJanssen Immunosciences, World Without Disease Accelerator, Pharmaceutical Companies of Johnson & Johnson, Beerse, Belgium.
Filip Van HauwermeirenJanssen Immunosciences, World Without Disease Accelerator, Pharmaceutical Companies of Johnson & Johnson, Beerse, Belgium.ORCID 0000-0001-9478-9994
Etienne MeunierInstitute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France.ORCID 0000-0002-3651-4877
Andy WullaertDepartment of Internal Medicine and Paediatrics, Ghent University, Ghent, Belgium.ORCID 0000-0001-5012-654X
Mohamed LamkanfiDepartment of Internal Medicine and Paediatrics, Ghent University, Ghent, Belgium.ORCID 0000-0002-4898-7663
Ghent University Hospital · BEJanssen (Belgium) · BECentre National de la Recherche Scientifique · FRUniversity of Antwerp · BEVIB-UGent Center for Inflammation Research · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neutrophils are the most prevalent immune cells in circulation, but the repertoire of canonical inflammasomes in neutrophils and their respective involvement in neutrophil IL-1β secretion and neutrophil cell death remain unclear. Here, we show that neutrophil-targeted expression of the disease-associated gain-of-function Nlrp3

Indexed as

Extracellular TrapsInflammasomesNeutrophilsPhosphate-Binding ProteinsPore Forming Cytotoxic ProteinsPyroptosisAnimalsGasderminsInterleukin-1betaIntracellular Signaling Peptides and ProteinsMiceMice, Inbred C57BLMitogensNADPNADPH OxidasesNLR Family, Pyrin Domain-Containing 3 ProteinGasderminsGsdmd protein, mouseInflammasomesInterleukin-1betaIntracellular Signaling Peptides and ProteinsMitogensNADPNADPH OxidasesNLR Family, Pyrin Domain-Containing 3 ProteinPhosphate-Binding ProteinsPore Forming Cytotoxic ProteinsPyringasdermin DinflammasomeNETosisneutrophilpyroptosis

Identifiers

PMID35899491
PMCPMC9535806
OpenAlexW4288080623

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.